CONTACT US

Publications

  • Kim, Kap-Ho, et al. “Anti-Diabetic Studies of Mass Cultured Mycelia from Ganoderma Applanatum in Db/Db Mice and Human.” The Korean Journal of Food and Nutrition Vol. 26. No. 3.366-374 (2013)

  • Journal of Natural Products, 67, 1110-1113 (2004)

  • American Chemical Society and American Society of Pharmacognosy Archives of Pharmacal Research, 29, 479-483 (2006)

  • Phytotherapy Research, 19, 477-480 (2005)

  • Biological and Pharmaceutical Bulletin, 28, 1103-1105 (2005)

  • Moradali MF, Mostafavi H, Hejaroude GA, Tehrani AS, Abbasi M, Ghods S. Investigation of potential antibacterial properties of methanol extracts from fungus Ganoderma applanatum. Chemotherapy. 2006;52(5):241-4. DOI: 10.1159/000094866. Epub 2006 Aug 4. PMID: 16899973.

  • Hossain MS, Barua A, Tanim MAH, Hasan MS, Islam MJ, Hossain MR, Emon NU, Hossen SMM. Ganoderma applanatum mushroom provides new insights into the management of diabetes mellitus, hyperlipidemia, and hepatic degeneration: A comprehensive analysis. Food Sci Nutr. 2021 Jun 24;9(8):4364-4374. DOI: 10.1002/fsn3.2407. PMID: 34401085; PMCID: PMC8358375.

  • Gao, X., Homayoonfal, M. Exploring the anti-cancer potential of Ganoderma lucidum polysaccharides (GLPs) and their versatile role in enhancing drug delivery systems: a multifaceted approach to combat cancer. Cancer Cell Int 23, 324 (2023).  https://doi.org/10.1186/s12935-023-03146-8

Product Research Information

Seoul National University & Chung Ang University.
Korea Natural Products Research Institute and College of Pharmacy
SANG HYUN LEE, SANG HEE, SHIM, JU SUN KIM, SAM SIK KANG and KAP HO KIM

Anti-Diabetic Studies of Mass-Cultured Mycelia from Ganoderma applanatum in db/db Mice and Human
KAP HO KIM, DALHOON SON, JOON SEOK LEE, JEONG WOON LEE, HAK SOO KIM, JAE HYEN LEE, MOON CHEOL LEE, NAMSIK KIM and SI WHAN SONG

New Lanostane-Type Triterpenoids from Ganoderma applanatum
SANG HEE SHIM, JIYOUNG RYU, JU SUN KIM, SAM SIK KANG, YONGNAN XU, SANG HOON JUNG, YEON SIL LEE, SANGHYUN LEE and KUK HYUN SHIN

Product Manufacturer Information

Miracle Life DKC Co.
HEILENEX PHARMA INC.
NHP GANODERMA

CEO SUNGSOON SON & DALHOON SON

Clinical Trials

  • Several animal studies (rats, dogs, hamsters and mice) were conducted in 2008.
  • Human clinical trial was conducted in 2012.
  • Statistically significant results were achieved, demonstrating that our product is safe and effective in the treatment of Type 2 diabetes without negative side effects.
  • The results of our accredited human clinical trial with a total of 56 subjects proved the safety and efficacy of Ganoderma Applanatum with the following results after 8 weeks of the trial:
      – The fasting blood sugar of the test group experienced a 69% reduction compared to control group
      – The blood sugar level of the test group decreased by 86.2%, two hours after meal consumption, compared to the control group
Product Manufacturer Information

Supply, Sales & Import

Worldwide Distributors: Dr. Allen

Recruiting global supply, sales, import and export agencies.

WEB www.jsdcando.com 

JSD Toronto Office
TEL (416) 909-5551  EMAIL info@jsdcando.com
565 Wilson Ave W114, North York, ON M3H 0C6

JSD New York Office
TEL (718) 578-7104 EMAIL keleenyus@gmail.com
56-15 251st St #1, Little Neck, NY 11362, USA

Testimonials

Client’s Reviews

Heilenex Pharma is the first and only company to hold a patent utilizing Ganoderma Applanatum for the treatment of diabetes.

Quick Links
Toronto
New York

HEILENE PHARMA INC. © All Rights Reserved.